Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$254M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$158M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$155M |
| 4 |
Intercontinental Exchange
ICE
|
+$116M |
| 5 |
Estee Lauder
EL
|
+$99.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$450M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$184M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$130M |
| 4 |
Hewlett Packard
HPE
|
+$119M |
| 5 |
GE Aerospace
GE
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Technology | 14.17% |
| 3 | Healthcare | 13.27% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3976
VolitionRx Ltd
VNRX
$5.49M
| $80K | ﹤0.01% |
1,136
| – | – |
2016 Q3
3 quarters
|
|
3977
Zevra Therapeutics
ZVRA
$593M
| $80K | ﹤0.01% |
1,256
| – | – |
2015 Q3
7 quarters
|
|
3978
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $80K | ﹤0.01% |
60,434
-240,583
| -80% | -$348K |
2013 Q2
16 quarters
|
|
3979
ChronoScale Holdings
CHRN
$2.18B
| $79K | ﹤0.01% |
152
| – | – |
2016 Q3
3 quarters
|
|
|
ARLZ
3980
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $79K | ﹤0.01% |
59,015
+6,616
| +13% | +$9.56K |
2016 Q1
5 quarters
|
|
3981
Perspective Therapeutics
CATX
$248M
| $78K | ﹤0.01% |
12,458
| – | – |
2013 Q2
16 quarters
|
|
3982
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.7B
| $78K | ﹤0.01% |
141,152
-17,472
| -11% | -$970K |
2013 Q2
16 quarters
|
|
|
BLPH
3983
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $78K | ﹤0.01% |
3,866
| – | – |
2017 Q1
1 quarter
|
|
3984
Phoenix New Media
FENG
$17.3M
| $77K | ﹤0.01% |
4,881
-1,279
| -21% | -$24.5K |
2015 Q4
6 quarters
|
|
3985
DELISTED
Regulus Therapeutics
RGLS
| $77K | ﹤0.01% |
656
-2,836
| -81% | -$473K |
2013 Q2
16 quarters
|
|
|
WTT
3986
DELISTED
Wireless Telecom Group, Inc.
WTT
| $77K | ﹤0.01% |
47,766
+4,072
| +9% | +$6.16K |
2013 Q2
16 quarters
|
|
3987
Genasys
GNSS
$60.1M
| $76K | ﹤0.01% |
44,888
| – | – |
2013 Q2
16 quarters
|
|
3988
Perma-Fix Environmental Services
PESI
$262M
| $76K | ﹤0.01% |
20,957
+560
| +3% | +$1.94K |
2013 Q2
16 quarters
|
|
3989
Senseonics Holdings Inc
SENS
$422M
| $76K | ﹤0.01% |
2,101
-12,605
| -86% | -$399K |
2016 Q2
4 quarters
|
|
|
DVD
3990
DELISTED
Dover Motorsports
DVD
| $76K | ﹤0.01% |
35,852
-345
| -1% | -$722 |
2013 Q2
16 quarters
|
|
|
OREX
3991
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $76K | ﹤0.01% |
26,267
-122
| -0.5% | -$366 |
2013 Q2
16 quarters
|
|
3992
DELISTED
Evoke Pharma
EVOK
| $75K | ﹤0.01% |
203
| – | – |
2017 Q1
1 quarter
|
|
3993
Good Times Restaurants
GTIM
$14.7M
| $75K | ﹤0.01% |
21,131
| – | – |
2015 Q2
8 quarters
|
|
3994
SCYNEXIS
SCYX
$35.7M
| $75K | ﹤0.01% |
521
| – | – |
2016 Q3
3 quarters
|
|
3995
SIFCO Industries
SIF
$130M
| $75K | ﹤0.01% |
11,280
+996
| +10% | +$7.39K |
2013 Q2
16 quarters
|
|
|
EGLT
3996
DELISTED
Egalet Corporation
EGLT
| $74K | ﹤0.01% |
31,148
-200,915
| -87% | -$641K |
2014 Q1
13 quarters
|
|
3997
DELISTED
Alpine Immune Sciences Inc
ALPN
| $73K | ﹤0.01% |
7,612
-525
| -6% | -$5.03K |
2015 Q3
7 quarters
|
|
3998
ClearSign Technologies
CLIR
$16.4M
| $72K | ﹤0.01% |
1,880
| – | – |
2013 Q2
16 quarters
|
|
3999
Westwater Resources
WWR
$52.1M
| $71K | ﹤0.01% |
950
| – | – |
2017 Q1
1 quarter
|
|
4000
Aldeyra Therapeutics
ALDX
$40.6M
| $70K | ﹤0.01% |
14,999
| – | – |
2015 Q2
8 quarters
|
|
Similar funds
Northern Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Northern Trust held 4,391 positions worth $358B, up 3.1% from $347B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Northern Trust's Q2 2017 filing shows 142 new, 2,528 increased, 1,287 reduced and 114 closed positions. Its largest new stake was DXC Technology: 3,833,711 shares worth $254M. The largest sale was Yahoo Inc, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q2 2017 buy was DXC Technology: 3,833,711 shares worth $254M.
- Northern Trust added most to Vanguard FTSE All-World ex-US ETF in Q2 2017, an estimated $158M increase.
- Northern Trust's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $119M.
- Northern Trust fully exited Yahoo Inc in Q2 2017, selling an estimated $450M.
- Northern Trust's ten largest holdings make up 14% of its $358B portfolio in Q2 2017.
- Northern Trust opened 142 new positions and closed 114 in Q2 2017.
- Northern Trust's portfolio value rose 3.1% quarter-over-quarter to $358B.
Based on Northern Trust's 13F filing for Q2 2017, filed 11 Aug 2017.